Danaher Corporation (DHR)
NYSEHealth CareDiagnostics & ResearchSnapshot 2026-07-08
$194.18+0.29%
Close 2026-07-07 · 1-day change
Reading DHR? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track DHR free→NYSEHealth CareDiagnostics & ResearchSnapshot 2026-07-08
Reading DHR? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track DHR free→QuarterlyIQ Insights · DHR
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT. Reference is made to the disclosure set forth under
OTHER EVENTS. On June 3, 2026, Danaher Corporation, a Delaware corporation (the “Company”), and its wholly owned subsidiary DH Masi Finance Inc., a Delaware corporation (the “Issuer”), entered into a note purchase and guaranty agreement among the Company, the Issuer and the institutional accredited investors named therein (the “Note Purchase Agreement”), relating to the issuance and sale of (i) CHF 119,500,000 aggregate principal amount of the Issuer’s 1.65% Senior Notes, Series A due June 3,…
Annual board election with no specific departures or appointments mentioned.
Entry into a Material Definitive Agreement On April 29, 2026, Danaher Corporation (“Danaher”) issued € 500,000,000 aggregate principal amount of Floating Rate Senior Notes due 2028 (the “Floating Rate Notes”), € 750,000,000 aggregate principal amount of 3.250% Senior Notes due 2030 (the “2030 Notes”), € 750,000,000 aggregate principal amount of 3.625% Senior Notes due 2034 (the “2034 Notes”) and € 1,000,000,000 aggregate principal amount of 4.000% Senior Notes due 2038 (the “2038 Notes” and,…
RESULTS OF OPERATIONS AND FINANCIAL CONDITION On April 21, 2026, Danaher Corporation (“Danaher”) issued a press release announcing financial results for the quarter ended March 27, 2026. A copy of the release is furnished herewith as Exhibit 99.1 and incorporated by reference herein. This Current Report on Form 8-K and the press release attached hereto are being furnished by Danaher pursuant to
CREATION OF A DIRECT FINANCIAL OBLIGATION OR AN OBLIGATION UNDER AN OFF-BALANCE SHEET ARRANGEMENT OF A REGISTRANT The information set forth under
ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT 364-Day Revolving Credit Facility On April 16, 2026, Danaher Corporation (“Danaher”) entered into a new $5.0 billion 364-day revolving credit facility (the “Credit Facility”) with Bank of America, N.A., as Administrative Agent, and a syndicate of lenders from time to time party thereto. The Credit Facility expires on April 15, 2027 (the “Scheduled Termination Date”). Danaher may elect, upon the payment of a fee equal to 0.50% of the principal amount…
The filing is about forward-looking statements and risks related to a potential transaction, not a management change.
OTHER EVENTS On February 17, 2026, Danaher Corporation, a Delaware corporation (the “ Company ”) issued a press release announcing entry into an Agreement and Plan of Merger (the “ Merger Agreement ”), dated February 16, 2026, by and among the Company, Masimo Corporation, a Delaware corporation (“ Masimo ”) and Mobius Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“ Merger Sub ”). Pursuant to the Merger Agreement, and upon the terms and conditions set for…
Director — Jessica L. Mega: Dr. Jessica L. Mega retired from the Board due to commitments related to her other professional obligations.
RESULTS OF OPERATIONS AND FINANCIAL CONDITION On January 28, 2026, Danaher Corporation (“Danaher”) issued a press release announcing financial results for the year ended December 31, 2025. A copy of the release is furnished herewith as Exhibit 99.1 and incorporated by reference herein. This Current Report on Form 8-K and the press release attached hereto are being furnished by Danaher pursuant to
of Form 8-K such press release as well as the presentation slides attached hereto, each of which is incorporated by reference herein. The presentation slides attached hereto contain certain information regarding Danaher’s estimated financial performance for 2025. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended,…
Director — John T. Schwieters: Mr. Schwieters decided not to stand for reelection and will retire from the Danaher Board at the 2026 Annual Meeting.
RESULTS OF OPERATIONS AND FINANCIAL CONDITION On October 21, 2025, Danaher Corporation (“Danaher”) issued a press release announcing financial results for the quarter ended September 26, 2025. A copy of the release is furnished herewith as Exhibit 99.1 and incorporated by reference herein. This Current Report on Form 8-K and the press release attached hereto are being furnished by Danaher pursuant to
OTHER EVENTS On September 9, 2025 , the Board of Directors of the Company approved a new share repurchase program authorizing the repurchase of up to 35 million shares of the Company’s common stock from time to time on the open market (including through the use of trading plans intended to qualify under Rule 10b5-1 under the Exchange Act of 1934, as amended), in privately negotiated transactions or by other methods, at the Company’s discretion. This authorization is in addition to, and does n…
General Counsel — Brian W. Ellis: Brian W. Ellis plans to relinquish his role as General Counsel but will continue in an executive officer role until retirement.
Chief Financial Officer — Matthew M. McGrew: Matthew M. McGrew is retiring from his role as Chief Financial Officer, and Matthew E. Gugino will succeed him.
RESULTS OF OPERATIONS AND FINANCIAL CONDITION On July 22, 2025, Danaher Corporation (“Danaher”) issued a press release announcing financial results for the quarter ended June 27, 2025. A copy of the release is furnished herewith as Exhibit 99.1 and incorporated by reference herein. This Current Report on Form 8-K and the press release attached hereto are being furnished by Danaher pursuant to
RESULTS OF OPERATIONS AND FINANCIAL CONDITION On April 22, 2025, Danaher Corporation (“Danaher”) issued a press release announcing financial results for the quarter ended March 28, 2025. A copy of the release is furnished herewith as Exhibit 99.1 and incorporated by reference herein. This Current Report on Form 8-K and the press release attached hereto are being furnished by Danaher pursuant to
Director — Charles W. Lamanna: Charles W. Lamanna was appointed to the Board of Directors and to the Science & Technology Committee.
RESULTS OF OPERATIONS AND FINANCIAL CONDITION On January 29, 2025, Danaher Corporation (“Danaher”) issued a press release announcing financial results for the year ended December 31, 2024. A copy of the release is furnished herewith as Exhibit 99.1 and incorporated by reference herein. This Current Report on Form 8-K and the press release attached hereto are being furnished by Danaher pursuant to
of Form 8-K such press release as well as the presentation slides attached hereto, each of which is incorporated by reference herein. The presentation slides attached hereto contain certain information regarding Danaher’s estimated financial performance for 2024. This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended,…
Director — Pardis C. Sabeti: Dr. Sabeti retired due to time commitments related to her other professional obligations.
RESULTS OF OPERATIONS AND FINANCIAL CONDITION On October 22, 2024, Danaher Corporation (“Danaher”) issued a press release announcing financial results for the quarter ended September 27, 2024. A copy of the release is furnished herewith as Exhibit 99.1 and incorporated by reference herein. This Current Report on Form 8-K and the press release attached hereto are being furnished by Danaher pursuant to
RESULTS OF OPERATIONS AND FINANCIAL CONDITION On July 23, 2024, Danaher Corporation (“Danaher”) issued a press release announcing financial results for the quarter ended June 28, 2024. A copy of the release is furnished herewith as Exhibit 99.1 and incorporated by reference herein. This Current Report on Form 8-K and the press release attached hereto are being furnished by Danaher pursuant to
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.